作者: Wolfgang A. G. Sauerwein , Pierre M. Bet , Andrea Wittig
DOI: 10.1007/978-3-642-31334-9_8
关键词:
摘要: This chapter is based on a shortened version of the investigators brochures from EORTC clinical trials 11001 and 11011 concerning boron compounds sodium borocaptate (BSH) boronophenylalanine (BPA). It summarizes essential information that might be asked by regulatory authorities. The intention this to support facilitate preparation new these compounds. However, compilation cannot offer complete final description all aspects 2 necessary file for drug approval.